Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

FOLLISTIM AQ

FOLLITROPIN ALFA/BETA

Standard Dose
300 IU/0.36ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FOLLISTIM AQ is listed in Drugs@FDA under application 021211 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FOLLITROPIN ALFA/BETA Form and strength INJECTABLE;SUBCUTANEOUS - 300 IU/0.36ML Sponsor ORGANON USA LLC Submission history Latest submission status date: 2026-02-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview FOLLISTIM AQ is listed in Drugs@FDA under application 021211 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOLLITROPIN ALFA/BETA Form and strength INJECTABLE;SUBCUTANEOUS - 300 IU/0.36ML Sponsor ORGANON USA LLC Submission history Latest submission status date: 2026-02-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FOLLISTIM AQ (FOLLITROPIN ALFA/BETA) | Drug Monograph | MedicHelpline